Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Marginal Zone Lymphoma

Clinical trial condition

Recurrent Marginal Zone Lymphoma

Explore clinical trials studying Recurrent Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

104 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Marginal Zone Lymphoma trial results

Active, Not Recruiting

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

NCT03147885

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +35 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Active, Not Recruiting

Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

NCT03015896

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +42 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

NCT04447716

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +17 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT02992522

Conditions: B-Cell, B-Cell Lymphoma, Unspecified, Burkitt Lymphoma, +30 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details